D018149DisordersC18.452.394.952.50013440.978335Glucose IntoleranceFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonWake Forest School of MedicineSuzanneCraftSuzanne Craft PhD36.08884000000000-80.270162000000001320Craft, SuzanneProfessorKylieKavanaghKylie Kavanagh VMS, MPH36.08943500000000-80.26863200000000530Kavanagh, KylieAssistant ProfessorLynneWagenknechtLynne E. Wagenknecht DrPH36.09562300000000-80.27569400000000595Wagenknecht, LynneProfessorAlainBertoniAlain Bertoni MD, MPH36.09550200000000-80.243937000000008Bertoni, AlainProfessorDonaldMcclainDonald A. Mcclain MD, PhD36.08977400000000-80.266840000000001732Mcclain, DonaldProfessor25968578Kwon OS, Tanner RE, Barrows KM, Runtsch M, Symons JD, Jalili T, Bikman BT, McClain DA, O'Connell RM, Drummond MJAmerican journal of physiology. Endocrinology and metabolismKwon OS, Tanner RE, Barrows KM, Runtsch M, Symons JD, Jalili T, Bikman BT, McClain DA, O'Connell RM, Drummond MJ. MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance. Am J Physiol Endocrinol Metab. 2015 Jul 01; 309(1):E11-21.Am J Physiol Endocrinol Metab2015-05-12T00:00:002015MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance.23210691Chuang CC, Shen W, Chen H, Xie G, Jia W, Chung S, McIntosh MKJournal of agricultural and food chemistryChuang CC, Shen W, Chen H, Xie G, Jia W, Chung S, McIntosh MK. Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fat-fed obese mice. J Agric Food Chem. 2012 Dec 26; 60(51):12458-68.J Agric Food Chem2012-12-14T00:00:002012Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fat-fed obese mice.20ProfessorInternal Medicine, Endocrinology & MetabolismInternal Medicine, Gerontology & Geriatric MedicinePsychiatry & Behavioral MedicinePublic Health Sciences (Division of)true1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessor23884776Festa A, Haffner SM, Wagenknecht LE, Lorenzo C, Hanley AJThe Journal of clinical endocrinology and metabolismFesta A, Haffner SM, Wagenknecht LE, Lorenzo C, Hanley AJ. Longitudinal decline of ß-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab. 2013 Oct; 98(10):4152-9.J Clin Endocrinol Metab2013-07-24T00:00:002013Longitudinal decline of ß-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.23033247Lin SX, Berlin I, Younge R, Jin Z, Sibley CT, Schreiner P, Szklo M, Bertoni AGDiabetes careLin SX, Berlin I, Younge R, Jin Z, Sibley CT, Schreiner P, Szklo M, Bertoni AG. Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2013 Feb; 36(2):342-7.Diabetes Care2012-10-01T00:00:002012Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the Multi-Ethnic Study of Atherosclerosis (MESA).23450048Lorenzo C, Hartnett S, Hanley AJ, Rewers MJ, Wagenknecht LE, Karter AJ, Haffner SMThe Journal of clinical endocrinology and metabolismLorenzo C, Hartnett S, Hanley AJ, Rewers MJ, Wagenknecht LE, Karter AJ, Haffner SM. Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. J Clin Endocrinol Metab. 2013 Apr; 98(4):1622-30.J Clin Endocrinol Metab2013-02-28T00:00:002013Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.0.841440.020613research area of0.5432850.049629838subject area for